tiprankstipranks

AdaptHealth price target lowered to $12 from $13 at UBS

UBS lowered the firm’s price target on AdaptHealth (AHCO) to $12 from $13 and keeps a Buy rating on the shares following the earnings report.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue